DROSHA and myelodysplastic syndrome: Taken together the observed downregulation of these genes in some MDS patients [25] and significant prevalence of mutations in their UTRs [26], call for analysis of these variants in the context of DICER1 and DROSHA regulation, specifically during MDS progression.